Decorative image

Monoclonal antibodies (MABS)

Monoclonal antibodies (MABs) are a type of targeted drug therapy. There are several MABS used to treat chronic lymphocytic leukaemia (CLL). Monoclonal antibodies are multiple copies of an individual antibody. Those used for CLL may disrupt the leukaemia cell processes so that the cell stops dividing or dies.

Rituximab (Mabthera)

Read about what rituximab is, how you have it and other important information about having rituximab for chronic lymphocytic leukaemia.

Alemtuzumab (MabCampath)

Find out what alemtuzumab is, how you have it and other important information about having alemtuzumab.

Last reviewed: 
20 Dec 2017
Coronavirus and cancer

We know it’s a worrying time for people with cancer, we have information to help.

Read our information about coronavirus and cancer